| Financial Year |
March 31 2023 |
| Monetary Funds |
1,016,775,145.05 |
| Held-for-trading Financial Assets |
40,519,232.86 |
| Notes Receivable |
5,681,217.14 |
| Accounts Receivable |
89,183,827.88 |
| Advances to Suppliers |
13,868,191.26 |
| Other Receivables |
10,542,235.53 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
556,505,827.89 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,651,324.04 |
| Total Current Assets |
1,736,811,988.97 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
2,467,015.38 |
| Fixed Assetes |
299,931,168.32 |
| Under-construction Projects |
51,120,690.39 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
60,795,119.54 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,121,585.37 |
| Deferred Income Tax Assets |
5,325,610.21 |
| Other Non-Current Assets |
4,669,533.29 |
| Sub-Total of Non-Current Assets |
439,362,663.50 |
| Total Assets |
2,176,174,652.47 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
86,762,429.76 |
| Accounts Payable |
123,352,726.15 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
21,772,531.11 |
| Taxes Payable |
12,049,697.25 |
| Interest Payable |
-- |
| Dividend Payable |
3,487,724.79 |
| Other payables |
14,014,865.26 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,763,868.98 |
| Other Current Liabilities |
50,871,287.75 |
| Sub-Total of Current Liabilities |
701,470,844.59 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
92,597.85 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,722,239.49 |
| Total Liabilities |
705,193,084.08 |
| Paid-In Capital(Or Share Stock) |
105,341,600.00 |
| Capital Surplus |
419,686,437.55 |
| Surplus Reserve |
132,510,918.81 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
777,589,142.19 |
| Minority Stockholder's Interest |
31,855,038.47 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,439,126,529.92 |
| Owner's Equity（Stockholder's Equity） |
1,470,981,568.39 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,176,174,652.47 |
